Avience Biomedicals Limited (NSE:AVIENCE)

Market Cap	1.37B
Revenue (ttm)	572.87M +417.5%
Net Income	97.51M +1,128.3%
EPS	20.50 +309.9%
Shares Out	5.49M
PE Ratio	12.19
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	16,200
Open	255.00
Previous Close	255.05
Day's Range	249.95 - 262.25
52-Week Range	208.00 - 414.95
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Feb 9, 2027

About Avience Biomedicals

Avience Biomedicals Limited manufactures and sells Vitro-Diagnostic products and medical devices in India. The company's products include reagents and consumables, such as biochemistry reagents, hematology reagents, immunoassay reagents, electrolyte reagents, and cuvettes, pipette tips, test tubes, microplates, and filters; diagnostic instruments and equipment includes automated biochemistry analysers, hematology analysers, immunoassay analysers, molecular diagnostic instruments, microbiology instruments and electrolyte analyser; rapid test kit...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2019
• Country: India
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: AVIENCE

Financial Performance

In fiscal year 2026, Avience Biomedicals's revenue was 525.16 million, an increase of 15.80% compared to the previous year's 453.50 million. Earnings were 87.53 million, an increase of 23.30%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Nov 11, 2026

Data Sources Report a data error